← 返回

白细胞介素-17 家族在癌症中的免疫生物学功能及治疗应用

英文原题:The immunobiological functions and therapeutic applications of interleukin-17 family in cancer.

查看英文原题

The immunobiological functions and therapeutic applications of interleukin-17 family in cancer.

PubMed 2025/07/02(内容时间) Curr Res Transl Med Q3 · IF 3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

白细胞介素-17(IL-17)家族细胞因子在免疫应答和炎症过程中发挥关键作用,显著影响多种生理和病理状态。本综述探讨了IL-17的免疫生物学功能,重点关注其多样的细胞来源,包括辅助性T细胞17(Th17)细胞、γδ T细胞、固有淋巴样细胞(ILCs)、中性粒细胞和自然杀伤T(NKT)细胞,以及相关信号通路。特别关注IL-17在癌症中的作用,其表现出促肿瘤和抗肿瘤双重效应,通过JAK/STAT、NF-κB和PI3K/AKT等多种信号级联影响肿瘤增殖、血管生成、转移和耐药性。理解这些机制凸显了IL-17作为调节免疫应答和改善癌症治疗的潜在治疗靶点。

展开英文摘要原文

Interleukin-17 (IL-17) family cytokines play a pivotal role in immune responses and inflammatory processes, significantly impacting various physiological and pathological conditions. This review explores the immunobiological functions of IL-17, focusing on its diverse cellular sources, including T helper 17 (Th17) cells, γδ T cells, innate lymphoid cells (ILCs), neutrophils, and natural killer T (NKT) cells, and signaling pathways.

Special attention is given to IL-17 involvement in cancer, where it exhibits both pro-tumorigenic and anti-tumorigenic effects, influencing tumor proliferation, angiogenesis, metastasis, and drug resistance through various signaling cascades such as JAK/STAT, NF-κB, and PI3K/AKT. Understanding these mechanisms highlights IL-17 as a potential therapeutic target for modulating immune responses and improving cancer treatments.

论文信息

作者
Mansuri N、Mohamed AH、Ahsan M、Ali SA、Qureshi MA、A Aldhaaban W、Mallick AK、Mohammed MED
第一作者单位
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.Saudi Arabia
通讯作者单位
Department of Optometry Techniques, Technical College Al-Mussaib, Al-Furat Al-Awsat Technical University, Najaf, Iraq. Electronic address: asmaa.muhammed@atu.edu.iq.United States
文献类型
综述
期刊
Current research in translational medicine2025 Dec
原文标识
PubMed 40644929 · DOI 10.1016/j.retram.2025.103527